Samrat Pharmachem Balance Sheet Annual

BSE: 530125 | NSE: - | ISIN: INE103E01016 | Sector: Biotechnology & Drugs

453.00 +12.05 (2.73%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.06	0.03	0.00	-
Cash Equivalents	9.67	11.86	14.71	2.54
Short Term Investments	0.01	0.01	0.01	0.00
Cashand Short Term Investments	9.74	11.91	14.72	2.54
Accounts Receivable- Trade Net	69.28	51.24	43.57	33.01
Total Receivables Net	69.28	51.24	43.59	33.02
Total Inventory	20.68	32.53	12.42	11.40
Other Current Assets Total	2.88	2.95	0.54	0.36
Total Current Assets	102.57	98.62	71.26	47.32
Property/ Plant/ Equipment Total- Net	10.72	10.70	9.98	9.39
Intangibles Net	0.01	0.01	0.01	0.01
Long Term Investments	7.56	6.54	3.16	0.00
Note Receivable- Long Term	0.28	0.24	0.21	0.20
Other Long Term Assets Total	0.61	0.05	0.00	0.46
Total Assets	121.74	116.15	84.61	57.40
Accounts Payable	47.67	31.88	23.39	17.66
Notes Payable/ Short Term Debt	8.45	18.66	7.52	8.79
Other Currentliabilities Total	0.28	2.21	6.42	0.87
Total Current Liabilities	56.40	52.75	37.33	27.33
Long Term Debt	0.00	-	-	0.00
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	8.45	18.66	7.52	8.79
Deferred Income Tax	0.34	0.25	0.46	0.43
Other Liabilities Total	0.00	-	-	0.00
Total Liabilities	56.74	53.01	37.79	27.76
Common Stock Total	3.09	3.09	3.09	3.09
Retained Earnings( Accumulated Deficit)	61.91	60.05	43.73	26.55
Total Equity	65.00	63.14	46.82	29.64
Total Liabilities Shareholders' Equity	121.74	116.15	84.61	57.40
Total Common Shares Outstanding	0.31	0.31	0.31	0.31
Tangible Book Valueper Share Common Eq	210.35	204.34	151.51	95.89